Addex Therapeutics (ADXN) Short Interest Ratio & Short Volume $8.04 -0.69 (-7.85%) Closing price 08/28/2025 03:50 PM EasternExtended Trading$7.86 -0.18 (-2.29%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Addex Therapeutics Short Interest DataAddex Therapeutics (ADXN) has a short interest of 1,200 shares, representing 0.15% of the float (the number of shares available for trading by the public). This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 884 shares to cover all short positions.Current Short Interest1,200 sharesPrevious Short Interest1,200 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$9.84 thousandShort Interest Ratio0.2 Days to CoverLast Record DateJuly 31, 2025Outstanding Shares1,060,000 sharesFloat Size819,300 sharesShort Percent of Float0.15%Today's Trading Volume485 sharesAverage Trading Volume884 sharesToday's Volume Vs. Average55% Short Selling Addex Therapeutics? Sign up to receive the latest short interest report for Addex Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartADXN Short Interest Over TimeADXN Days to Cover Over TimeADXN Percentage of Float Shorted Over Time Addex Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/20251,200 shares $9.84 thousand No Change0.2%0.2 $8.20 7/15/20251,200 shares $10.83 thousand -45.5%0.2%0.2 $9.03 6/30/20252,200 shares $20.70 thousand No Change0.3%0.3 $9.41 6/15/20252,200 shares $18.14 thousand -4.4%0.3%0.4 $8.24 5/31/20252,300 shares $17.81 thousand -14.8%0.3%0.4 $7.75 5/15/20252,700 shares $21.82 thousand -6.9%0.3%0.4 $8.08 4/30/20252,900 shares $22.59 thousand +45.0%0.4%0.4 $7.79 4/15/20252,000 shares $14.60 thousand -44.4%0.2%0.2 $7.30 3/31/20253,600 shares $26.42 thousand +227.3%0.4%0.2 $7.34 3/15/20251,100 shares $8.06 thousand -15.4%0.1%0.1 $7.33 Get the Latest News and Ratings for ADXN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Addex Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/28/20251,300 shares $11.05 thousand -23.5%0.2%0.1 $8.50 2/15/20251,700 shares $12.74 thousand +13.3%0.2%0.1 $7.50 1/31/20251,500 shares $11.55 thousand -54.6%0.2%0 $7.70 1/15/20253,300 shares $25.03 thousand -42.1%0.4%0.1 $7.59 12/31/20245,700 shares $39.90 thousand -34.5%0.7%0.1 $7.00 12/15/20248,700 shares $69.60 thousand -43.1%1.1%0.2 $8.00 11/30/202415,300 shares $133.26 thousand -16.9%1.9%0.3 $8.71 11/15/202418,400 shares $148.30 thousand +425.7%2.3%0.1 $8.06 10/31/20243,500 shares $34.13 thousand -64.7%0.4%0 $9.75 10/15/20249,900 shares $103.46 thousand +3.1%1.2%0 $10.45 9/30/20249,600 shares $93.79 thousand -62.2%1.2%0 $9.77 9/15/202425,400 shares $244.86 thousand -74.0%3.1%0.1 $9.64 8/31/202497,500 shares $1.06 million +9,650.0%11.9%0.4 $10.86 8/15/20241,000 shares $7.80 thousand -23.1%0.1%0.3 $7.80 7/31/20241,300 shares $10.86 thousand -23.5%0.2%0.4 $8.35 7/15/20241,700 shares $14.14 thousand -39.3%0.2%0.2 $8.32 6/30/20242,800 shares $23.02 thousand -40.4%0.3%0.2 $8.22 6/15/20244,700 shares $40.47 thousand -27.7%0.6%0.3 $8.61 5/31/20246,500 shares $55.90 thousand +18.2%0.8%0.3 $8.60 5/15/20245,500 shares $49.50 thousand -62.6%0.7%0.3 $9.00 4/30/202414,700 shares $112.46 thousand -32.3%1.9%0.8 $7.65 4/15/202421,700 shares $537.08 thousand +149.4%2.7%1.3 $24.75 3/31/20248,700 shares $111.36 thousand -26.9%0.9%0.5 $12.80 3/15/202411,900 shares $139.35 thousand +41.7%1.2%1.2 $11.71 2/29/20248,400 shares $79.88 thousand +33.3%0.8%0.9 $9.51 2/15/20246,300 shares $66.09 thousand -27.6%0.6%0.7 $10.49 1/31/20248,700 shares $94.31 thousand +222.2%0.9%0.8 $10.84 1/15/20242,700 shares $18.77 thousand +12.5%0.3%0.3 $6.95 12/31/20232,400 shares $14.52 thousand -33.3%0.2%0.2 $6.05 12/15/20233,600 shares $19.55 thousand -14.3%0.4%0.4 $5.43Man Who Called Nvidia at $1.10 Says Buy This Now... (Ad)In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new company could become the next to soar like Nvidia.Watch Alex's "Next Magnificent Seven" presentation now. 11/30/20234,200 shares $23.31 thousand -25.0%0.5%0.5 $5.55 11/15/20235,600 shares $34.16 thousand +5.7%0.8%0.8 $6.10 10/31/20235,300 shares $33.34 thousand No Change0.8%1 $6.29 10/15/20235,300 shares $43.04 thousand -95.4%N/A1.3 $8.12 9/30/2023115,900 shares $44.54 thousand -35.0%N/A1.7 $0.38 9/15/2023178,200 shares $74.84 thousand +76.1%N/A3.3 $0.42 8/31/2023101,200 shares $46.25 thousand -8.9%N/A2 $0.46 8/15/2023111,100 shares $59.22 thousand -4.4%N/A1.7 $0.53 7/31/2023116,200 shares $65.07 thousand -16.6%N/A0.3 $0.56 7/15/2023139,400 shares $82.11 thousand -13.6%N/A0.4 $0.59 6/30/2023161,300 shares $84.04 thousand -28.7%N/A0.4 $0.52 6/15/2023226,300 shares $149.36 thousand -40.4%3.0%0.5 $0.66 5/31/2023379,900 shares $246.59 thousand -43.6%5.1%0.7 $0.65 5/15/2023673,100 shares $567.09 thousand +358.5%9.0%1.2 $0.84 4/30/2023146,800 shares $104.18 thousand -34.2%N/A0.4 $0.71 4/15/2023223,100 shares $172.98 thousand +195.9%N/A0.5 $0.78 3/31/202375,400 shares $71.34 thousand -7.6%N/A0.2 $0.95 3/15/202381,600 shares $89.76 thousand -75.9%N/A0.3 $1.10 2/28/2023338,700 shares $694.34 thousand +149.8%N/A1.1 $2.05 2/15/2023135,600 shares $203.40 thousand -55.2%N/A0.5 $1.50 1/31/2023302,400 shares $323.57 thousand +484.9%N/A1.3 $1.07 1/15/202351,700 shares $44.98 thousand +28.0%N/A0.3 $0.87 12/30/202240,400 shares $25.46 thousand +15.8%0.5%0.3 $0.63 12/15/202234,900 shares $21.15 thousand -25.3%0.9%0.3 $0.61 11/30/202246,700 shares $35.95 thousand -57.4%1.6%0.3 $0.77 11/15/2022109,700 shares $89.42 thousand +247.2%3.6%0.7 $0.82 10/31/202231,600 shares $26.86 thousand -41.6%0.6%0.2 $0.85 10/15/202254,100 shares $43.28 thousand -43.1%0.9%0.2 $0.80 9/30/202295,100 shares $76.06 thousand +37.0%1.7%0 $0.80 9/15/202269,400 shares $66.62 thousand -46.7%1.2%0 $0.96 8/31/2022130,300 shares $140.72 thousand -11.2%2.3%0 $1.08 8/15/2022146,800 shares $204.05 thousand -30.0%2.6%0.1 $1.39 7/31/2022209,800 shares $242.89 thousand +11,555.6%3.4%0.1 $1.16 7/15/20221,800 shares $1.78 thousand -71.9%0.0%0 $0.99 6/30/20226,400 shares $7.36 thousand +106.5%0.1%0.2 $1.15 6/15/20223,100 shares $10.57 thousand +29.2%0.1%0.1 $3.41 5/31/20222,400 shares $9.05 thousand +2,300.0%0.0%0.5 $3.77 5/15/2022100 shares $417.00 -80.0%N/A0 $4.17 4/30/2022500 shares $2.59 thousand +25.0%N/A0.2 $5.18 4/15/2022400 shares $1.75 thousand +300.0%N/A0.1 $4.39 3/31/2022100 shares $508.00 -50.0%N/A0 $5.08 3/15/2022200 shares $908.00 No ChangeN/A0.1 $4.54 2/28/2022200 shares $1.06 thousand No ChangeN/A0 $5.31 2/15/2022200 shares $1.14 thousand -93.3%N/A0 $5.70 1/31/20223,000 shares $17.19 thousand +500.0%0.1%0.7 $5.73 1/15/2022500 shares $2.99 thousand -96.4%0.0%0.1 $5.97 12/31/202113,800 shares $86.80 thousand +885.7%0.3%4.3 $6.29 12/15/20211,400 shares $9.11 thousand -12.5%0.0%0.5 $6.51 11/30/20211,600 shares $11.22 thousand +6.7%0.0%0.8 $7.01 11/15/20211,500 shares $12.06 thousand +87.5%0.0%0.8 $8.04Man Who Called Nvidia at $1.10 Says Buy This Now... (Ad)In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new company could become the next to soar like Nvidia.Watch Alex's "Next Magnificent Seven" presentation now. 10/29/2021800 shares $6.31 thousand -11.1%0.0%0.4 $7.89 10/15/2021900 shares $7.66 thousand -25.0%0.0%0.4 $8.51 9/30/20211,200 shares $10.81 thousand -63.6%0.0%0.3 $9.01 9/15/20213,300 shares $32.04 thousand -13.2%0.1%0.8 $9.71 8/31/20213,800 shares $36.97 thousand +111.1%0.1%0.8 $9.73 8/13/20211,800 shares $17.87 thousand +157.1%0.0%0.4 $9.93 7/30/2021700 shares $6.90 thousand -69.6%0.0%0.1 $9.85 7/15/20212,300 shares $22.20 thousand +1,050.0%N/A0.4 $9.65 6/30/2021200 shares $1.91 thousand -96.0%N/A0 $9.56 6/15/20215,000 shares $55 thousand +354.6%N/A0.7 $11.00 5/28/20211,100 shares $10.29 thousand -73.2%N/A0.2 $9.35 5/14/20214,100 shares $37.06 thousand -43.1%N/A0.4 $9.04 4/30/20217,200 shares $71.93 thousand +200.0%N/A0.4 $9.99 4/15/20212,400 shares $25.13 thousand +140.0%N/A0.1 $10.47 3/31/20211,000 shares $10.40 thousand -47.4%N/A0 $10.40 3/15/20211,900 shares $20.50 thousand -71.2%N/A0 $10.79 2/26/20216,600 shares $74.58 thousand +57.1%N/A0.1 $11.30 2/12/20214,200 shares $47.88 thousand -67.9%N/A0 $11.40 1/29/202113,100 shares $144.76 thousand +1,090.9%N/A0.1 $11.05 1/15/20211,100 shares $11.81 thousand No ChangeN/A0 $10.74 ADXN Short Interest - Frequently Asked Questions What is Addex Therapeutics' current short interest? Short interest is the volume of Addex Therapeutics shares that have been sold short but have not yet been covered or closed out. As of July 31st, investors have sold 1,200 shares of ADXN short. 0.15% of Addex Therapeutics' shares are currently sold short. Learn More on Addex Therapeutics' current short interest. What is a good short interest percentage for Addex Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.15% of Addex Therapeutics' floating shares are currently sold short. What is Addex Therapeutics' float size? Addex Therapeutics currently has issued a total of 1,060,000 shares. Some of Addex Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Addex Therapeutics currently has a public float of 819,300 shares. How does Addex Therapeutics' short interest compare to its competitors? 0.15% of Addex Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Addex Therapeutics: SCYNEXIS, Inc. (1.40%), Akari Therapeutics PLC (0.15%), Clearside Biomedical, Inc. (2.70%), Mural Oncology PLC (2.01%), BioXcel Therapeutics, Inc. (4.84%), Dyadic International Inc. (0.37%), Kezar Life Sciences, Inc. (9.46%), MIRA Pharmaceuticals, Inc. (3.01%), Tenax Therapeutics, Inc. (9.22%), Cadrenal Therapeutics, Inc. (2.39%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), Strategy Inc ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks. What does it mean to sell short Addex Therapeutics stock? Short selling ADXN is an investing strategy that aims to generate trading profit from Addex Therapeutics as its price is falling. ADXN shares are trading down $0.69 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Addex Therapeutics? A short squeeze for Addex Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ADXN, which in turn drives the price of the stock up even further. How often is Addex Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ADXN, twice per month. The most recent reporting period available is July, 31 2025. More Short Interest Resources from MarketBeat Related Companies SCYX Short Interest Data AKTX Short Interest Data CLSD Short Interest Data MURA Short Interest Data BTAI Short Interest Data DYAI Short Interest Data KZR Short Interest Data MIRA Short Interest Data TENX Short Interest Data CVKD Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ADXN) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Addex Therapeutics Ltd. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Addex Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access